Please assess the completion status of the following clinical trial:

Trial Title: The Impact of Treating Minor Uterine Cavity Abnormalities Diagnosed by Office Hysteroscopy in Unselected In Vitro Fertilization (IVF) Cases

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: NONE
- Phase: PHASE2
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Normal Transvaginal Ultrasound~* No prior hysteroscopy~* Regular menstrual cycle~* Single embryo transfer~* BMI between 18 and 29~* Presence of both ovaries~* Primary or secondary infertility~* Women indicated for a first IVF/ICSI cycle~Exclusion Criteria:~* Recurrent miscarriage~* Prior hysteroscopic treatments~* Endometriosis \> AFS Stage II~* Meno-metrorrhagia (defined as any intermenstrual loss of blood)~* Submucosal/Intracavitary Fibroids taking more than 50% of the cavity~* Hydrosalpinx~* FSH/LH \> 12IU/L on day 3~* Polyps taking more than 50% of the cavity~* Severe adhesions \> grade II

- Gender: FEMALE
- Minimum Age: None
- Maximum Age: 36 Years
- Healthy Volunteers: t

Study Arms:
- 1 (Type: NO_INTERVENTION): One or more of the predefined minor intra-uterine abnormalities have been detected, but not treated during hysteroscopy.
- 2 (Type: ACTIVE_COMPARATOR): One or more of the predefined minor intra-uterine abnormalities have been detected and treated during hysteroscopy.

Based on this trial design, predict the completion outcome and termination type (if applicable).